NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email In today’s episode of “Uncanny Valley,” we dive into five stories—from AI to DOGE—that encapsulate the year and give us clues as to what might unfold in 2026.Read More